Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mukhtyar C et al. – A review summarizes data available for the effect of primary systemic vasculitis on cardiovascular endpoints (coronary artery disease, congestive cardiac failure, hypertension, aortic aneurysm) in all age groups. A discussion is presented of the interplay between activated endothelium, autoimmune mechanisms and treatment factors to produce a direct insult or increased atherogenic potential of primary systemic vasculitis. Recommendations for cardiovascular endpoints are offered.


Today in Vasculitic Syndromes...keeping you current

One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçets disease refractory to standard immunosuppressive drugs
Rheumatology International, 10/30/09

Vasculitis in Children and Adolescents: Clinical Presentation, Etiopathogenesis, and Treatment
Pediatric Drugs, 11/11/09

Management of acute coronary syndrome in a case of Behcets disease
Blood Coagulation & Fibrinolysis, 11/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address